Navigation Links
Memory Pharmaceuticals Receives Nasdaq Notification
Date:4/4/2008

disease and schizophrenia. For additional information, please visit our website at http://www.memorypharma.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. All statements, other than statements of historical facts, regarding management's expectations, beliefs, goals, plans or Memory Pharmaceuticals' prospects, future financial position, future revenues and projected costs should be considered forward-looking. Readers are cautioned that actual results may differ materially from projections or estimates due to a variety of important factors, including the outcome of clinical trials of Memory Pharmaceuticals' drug candidates and whether they demonstrate these candidates' safety and effectiveness; the risks and uncertainties associated with: obtaining additional financing to support Memory Pharmaceuticals' R&D and clinical activities and operations; obtaining regulatory approvals to conduct clinical trials and to commercialize Memory Pharmaceuticals' drug candidates; Memory Pharmaceuticals' ability to enter into and maintain collaborations with third parties for its drug development programs; Memory Pharmaceuticals' dependence on its collaborations and its license relationships; achieving milestones under Memory Pharmaceuticals' collaborations; Memory Pharmaceuticals' dependence on preclinical and clinical investigators, preclinical and clinical research organizations, manufacturers and consultants; protecting the intellectual property developed by or licensed to Memory Pharmaceuticals; and Memory Pharmaceuticals' ability to maintain listing on the Nasdaq Global Market. These and other risks are described in greater detail in Memory Pharmaceuticals' filings with the Securities and Exchange Commission. Memory Pharmaceuticals may not actually achieve t
'/>"/>

SOURCE Memory Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Memory Pharmaceuticals Receives Audit Opinion Containing Going Concern Qualification
2. Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs
3. Memory Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Results on Thursday, March 6, 2008
4. Memory Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
5. Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment
6. Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia
7. Memory Pharmaceuticals to Announce Third Quarter Results on Thursday, November 8, 2007
8. ASU researchers improve memory devices using nanotech
9. BioMedical Enterprises, Inc. (BME) Receives FDA Clearance for Spine Use of Its Memory Metal Implants
10. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
11. Scientists synthesize memory in yeast cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... Washington, USA (PRWEB) November 23, 2014 One ... dynamic field of optics and photonics is now available to ... or very low cost. SPIE, the international society for ... access to the complete SPIE Digital Library available ... subsidized price. , “Light-based technologies are integral to all areas ...
(Date:11/24/2014)... (PRWEB) November 24, 2014 The ... ” from METTLER TOLEDO demonstrates how to reduce ... Power analytics and sample panel design can be ... chemistry and protect against corrosion and deposition. Dedicated ... a significant amount of panel space. Additionally, installing ...
(Date:11/23/2014)... 2014 Apiscent Labs, a privately ... chemical ingredients to the global pharmaceutical and flavor ... new website, Apiscent.com. , The Apiscent.com homepage welcomes ... design, easy navigation, rotating images and content focused ... out. , The company’s work in ...
(Date:11/22/2014)... Prominent academics, leaders of the ... December 3rd at Genetic Rx, a networking conference ... take place at the Joseph B. Martin Conference ... the present and future of genetic medicines—including siRNA, ... editing—as well as the treatment of patients with ...
Breaking Biology Technology:SPIE Digital Library Now Available to High Schools, Two-Year Colleges at No or Low Cost 2New Video Shows How to Simplify Cycle Chemistry Sample Panels to Save Time and Costs 2Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2
... Pa., April 12, 2011 Morphotek®, Inc., a subsidiary ... received a grant of approximately $947,000 from the United ... development of therapeutic monoclonal antibodies (mAbs) capable of neutralizing ... project is part of a U.S. defense initiative to ...
... EMC Corporation (NYSE: EMC ), the world ... Medical Research Institute , which ranks among the top four ... and among the top 25 organizations worldwide for its research ... as the primary storage platform for its wide range ...
... 12, 2011 Sanford Rose Associates - Charleston, ... healthcare information technology, has promoted Bonnie R. Siegel ... Practice. Health information technology continues to ... trillion global healthcare marketplace. Bonnie will continue to ...
Cached Biology Technology:Morphotek Receives Grant to Support Development of Therapeutic Antibodies against Biowarfare Agents 2Morphotek Receives Grant to Support Development of Therapeutic Antibodies against Biowarfare Agents 3Sanford-Burnham Turns Big Data Into Scientific Breakthroughs With EMC Isilon 2Sanford-Burnham Turns Big Data Into Scientific Breakthroughs With EMC Isilon 3Sanford Rose Associates - Charleston Promotes Bonnie Siegel to Partner 2
(Date:11/18/2014)... Nov. 18, 2014   EyeLock Inc. , ... and MorphoTrust USA (Safran), a leading ... announced a strategic partnership to offer comprehensive biometric ... administration (MVA), airport screening and financial services markets. ... MorphoTrust serves consumers through a nationwide network of ...
(Date:11/7/2014)... associate professor, biomedical engineering, in the Grove School ... York, have identified a molecule that could lead ... aggressive forms of breast cancer. , Triple negative ... owing to aggressive proliferation and metastasis and a ... team, discovered the overexpression of intercellular adhesion molecule-1 ...
(Date:11/6/2014)... is an asset for a predator. Except when that predator ... tiger beetle, relative to its size, is the fastest creature ... body lengths per second (at about five miles per hour). ... take the sprinting gold from the tiger beetle, a person ... The tiger beetle has a problem. At peak speeds, everything ...
Breaking Biology News(10 mins):EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3The tiger beetle: Too fast to see 2
... The global fight against the tuberculosis epidemic receives a ... Group (CNBG) announce that they have reached final agreement ... between the leading non-profit developer of TB vaccine candidates ... commitment by both to engage and strengthen the role ...
... Representatives of a giant tortoise species that had apparently ... ago must be alive today, if in very small numbers. ... Biology, a Cell Press publication, have come to this ... Chelonoidis elephantopus in the DNA of their hybrid ...
... WEST LAFAYETTE, Ind. - Modified probiotics, the beneficial ... one day decrease the risk of Listeria ... Purdue University research. Arun Bhunia, a professor of ... and Ok Kyung Koo, a former Purdue doctoral student, ...
Cached Biology News:Aeras and CNBG sign agreement on tuberculosis vaccine R&D 2'Extinct' for 150 years, an iconic Galpagos giant tortoise species lives 2Pill some day may prevent serious foodborne illness, scientist says 2
7G10 anti-Fasciclin III...
Sheep polyclonal to Salmonella Shoreditch ( Abpromise for all tested applications). Antigen: Native Salmonella shoreditch (Group D2)....
Rabbit polyclonal to ZA20D3 ( Abpromise for all tested applications). entrezGeneID: 54469 SwissProtID: Q6FIF0...
... for all tested applications). ... from within residues 1 - 100 of Mouse ... proprietary) (Peptide available as ... 5453 Swiss Protein ID: ...
Biology Products: